Heart disease is down, gout is up, biosimilars confuse patients and more from EULAR 2017. (Photo courtesy of EULAR, 6282)
Very Early Rheumatoid Arthritis Responds to Abatacept
Patients with higher MRI inflammation in hand and wrist RA may derive greater benefit from abatacept with methotrexate instead of methotrexate alone.
Baricitinib May Not Increase Infections in Rheumatoid Arthritis
EULAR 2017: The drug also lowered the rate of joint damage progression and maintained an overall low disease activity.
Rethinking Pain Management in Psoriatic Arthritis
EULAR 20017: Despite the use of biologic therapy, pain ranging from mild to severe is a persistent problem for psoriatic arthritis patients, researchers reported at EULAR 2017.
Heart Disease in Lupus More Common than Previously Thought
EULAR 2017: Although already known to be highly prevalent, this test reveals that cardiovascular events are even more widespread in lupus.
Heart Disease is Down, Gout is Up, Biosimilars Confuse Patients and more from EULAR 2017
EULAR 2017 wraps on Saturday. In this slideshow, we highlight some of the most popular presentations from the meeting.
Better to Treat Rheumatoid Arthritis in its Early Stages
EULAR 2017: Undifferentiated arthritis or very early rheumatoid arthritis should be treated soon after diagnosis to prevent advanced arthritis.
Romosozumab Continues to Build Bone, Reduce Fracture Risk
EULAR 2017: Romosozumab reduces the risk of clinical vertebral fractures in postmenopausal women with osteoporosis by as much as five times.
By clicking Accept, you agree to become a member of the UBM Medica Community.